Giulia Roda
University of Bologna
Publications 74
#1Catherine Le Berre (University of Lorraine)H-Index: 1
#2Giulia RodaH-Index: 17
Last.Laurent Peyrin-Biroulet (University of Lorraine)H-Index: 59
view all 5 authors...
ABSTRACTIntroduction: For 30 years, 5-aminosalicylic acid (5-ASA) has been the backbone of therapeutic management in patients with ulcerative colitis (UC). In the biologic era, it still remains the...
#1Silvio Danese (Humanitas University)H-Index: 63
#2Giulia RodaH-Index: 17
Last.Laurent Peyrin-Biroulet (French Institute of Health and Medical Research)H-Index: 59
view all 3 authors...
In ulcerative colitis, treating beyond endoscopic healing has shown a reduction of relapse and hospitalization, pushing for histological remission to be embraced in clinical practice and clinical trials. Here, we propose the concept of disease clearance (symptomatic, endoscopic and histological remission) as the ultimate goal in the treatment of ulcerative colitis.
#1Giulia RodaH-Index: 17
#2Emanuele PorruH-Index: 3
Last.Aldo RodaH-Index: 54
view all 9 authors...
Background: Inflammatory bowel diseases (IBD), ulcerative colitis (UC), and Crohn’s disease (CD), represent systematic chronic conditions with a deficient intestinal absorption. We first attempt to investigate the serum bile acids (sBAs) profile in a large cohort of IBD patients to evaluate changes under anti-TNF alpha treatment. Methods: Forty CD and 40 UC patients were enrolled and BAs were quantified by high-pressure liquid chromatography-electrospray-tandem mass spectrometry (HPLC-ES-MS/MS)....
#1Laura LoyH-Index: 1
#2Giulia RodaH-Index: 17
Last.Silvio DaneseH-Index: 63
view all 8 authors...
ABSTRACTIntroduction: Inflammatory bowel diseases, which include Crohn’s disease and ulcerative colitis, are lifetime chronic and progressive disorders of poorly known etiology.Over the past few decades, new therapeutic approaches, including early and more aggressive intervention with immunomodulators and biological agents have offered the possibility of a favorable modification in the natural history of inflammatory bowel diseases.Area covered: Here, we review the literature about the effective...